Training Program in Personalized Cardiovascular Medicine (TPIPCVM)

个性化心血管医学培训计划 (TPIPCVM)

基本信息

  • 批准号:
    10454147
  • 负责人:
  • 金额:
    $ 40.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

TRAINING IN PERSONALIZED CARDIOVASCULAR MEDICINE (TPIPCVM) Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
个体化心血管医学培训(tpipcvm)

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nicotinamide restores tissue NAD+ and improves survival in rodent models of cardiac arrest.
  • DOI:
    10.1371/journal.pone.0291598
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis.
Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.
  • DOI:
    10.1172/jci.insight.155640
  • 发表时间:
    2022-04-08
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Ly, Olivia T.;Chen, Hanna;Brown, Grace E.;Hong, Liang;Wang, Xinge;Han, Yong Duk;Pavel, Mahmud Arif;Sridhar, Arvind;Maienschein-Cline, Mark;Chalazan, Brandon;Ong, Sang-Ging;Abdelhady, Khaled;Massad, Malek;Rizkallah, Lona Ernst;Rehman, Jalees;Khetani, Salman R.;Darbar, Dawood
  • 通讯作者:
    Darbar, Dawood
Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.
肥厚性心肌病的病理生理学中的冠状动脉血管。
Atrial Fibrillation in Inherited Channelopathies.
  • DOI:
    10.1016/j.ccep.2020.10.004
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Al-Azaam, Baha'a;Darbar, Dawood
  • 通讯作者:
    Darbar, Dawood
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dawood Darbar其他文献

Dawood Darbar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dawood Darbar', 18)}}的其他基金

Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10671651
  • 财政年份:
    2020
  • 资助金额:
    $ 40.29万
  • 项目类别:
Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10453452
  • 财政年份:
    2020
  • 资助金额:
    $ 40.29万
  • 项目类别:
Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
人 iPSC 衍生的心房心肌细胞在培养皿中模拟心房颤动
  • 批准号:
    10549330
  • 财政年份:
    2020
  • 资助金额:
    $ 40.29万
  • 项目类别:
Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10215617
  • 财政年份:
    2020
  • 资助金额:
    $ 40.29万
  • 项目类别:
Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
人 iPSC 衍生的心房心肌细胞在培养皿中模拟心房颤动
  • 批准号:
    10548469
  • 财政年份:
    2020
  • 资助金额:
    $ 40.29万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10477286
  • 财政年份:
    2019
  • 资助金额:
    $ 40.29万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10266061
  • 财政年份:
    2019
  • 资助金额:
    $ 40.29万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    9974275
  • 财政年份:
    2019
  • 资助金额:
    $ 40.29万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10905978
  • 财政年份:
    2019
  • 资助金额:
    $ 40.29万
  • 项目类别:
Training Program in Personalized Cardiovascular Medicine (TPIPCVM)
个性化心血管医学培训计划 (TPIPCVM)
  • 批准号:
    10204788
  • 财政年份:
    2018
  • 资助金额:
    $ 40.29万
  • 项目类别:

相似国自然基金

Chinese Journal of Integrative Medicine
  • 批准号:
    81224004
  • 批准年份:
    2012
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Personalised Adaptive Medicine
个性化适应性医学
  • 批准号:
    10100435
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    EU-Funded
Amalgamating Evidence About Causes: Medicine, the Medical Sciences, and Beyond
合并有关原因的证据:医学、医学科学及其他领域
  • 批准号:
    AH/Y007654/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London Sch of Hygiene & Tropic. Medicine
2024 年开放访问区块奖 - 伦敦卫生学院
  • 批准号:
    EP/Z532368/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Research Grant
CageTag: Caged Theranostics as a Universal Platform for Nuclear Medicine
CageTag:笼式治疗诊断学作为核医学的通用平台
  • 批准号:
    EP/V055836/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Research Grant
Planning: FIRE-PLAN: Exploring fire as medicine to revitalize cultural burning in the Upper Midwest
规划:FIRE-PLAN:探索火作为药物,以振兴中西部北部的文化燃烧
  • 批准号:
    2349282
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Standard Grant
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
  • 批准号:
    2226026
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Cooperative Agreement
REU site: Research at the interface between engineering and medicine (ENGMED)
REU 网站:工程与医学之间的交叉研究 (ENGMED)
  • 批准号:
    2349731
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Standard Grant
NSF Engines: Piedmont Triad Regenerative Medicine Engine
NSF 引擎:Piedmont Triad 再生医学引擎
  • 批准号:
    2315654
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Cooperative Agreement
関節リウマチにおけるPrecision medicine達成のための科学的根拠の確立
为实现类风湿关节炎精准医疗奠定科学基础
  • 批准号:
    24K11609
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
胆道癌における相同組換え修復欠損に基づいたprecision medicineの構築
基于胆道癌同源重组修复缺陷的精准医疗构建
  • 批准号:
    24K11926
  • 财政年份:
    2024
  • 资助金额:
    $ 40.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了